Mixing theory for culture and harvest in bioreactors of human mesenchymal stem cells on microcarriers
- Authors: Nienow A.W.1,2, Rafiq Q.A.2,3, Heathman T.R.2, Coopman K.2, Hewitt C.J.2,3
-
Affiliations:
- School of Chemical Engineering
- Centre for Biological Engineering
- Aston Medical Research Institute
- Issue: Vol 50, No 6 (2016)
- Pages: 895-900
- Section: Proceedings of XXV European Conference on Mixing “MIXING 15”
- URL: https://journals.rcsi.science/0040-5795/article/view/171183
- DOI: https://doi.org/10.1134/S0040579516060117
- ID: 171183
Cite item
Abstract
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advance for the treatment of many medical conditions, especially with the use of allogeneic therapies where the cells from a single donor can be used to treat ailments in many patients. Such cells must be grown attached to surfaces and for large scale production, it is shown that stirred bioreactors containing ~200 μm particles (microcarriers) can provide such a surface. It is also shown that the just suspended condition, agitator speed NJS, provides a satisfactory condition for cell growth by minimizing the specific energy dissipation rate, εT, in the bioreactor whilst still meeting the oxygen demand of the cells. For the cells to be used for therapeutic purposes, they must be detached from the microcarriers before being cryopreserved. A strategy based on a short period (~7 min) of very high εT, based on theories of secondary nucleation, is effective at removing >99% cells. Once removed, the cells are smaller than the Kolmogorov scale of turbulence and hence not damaged. This approach is shown to be successful for culture and detachment in 4 types of stirred bioreactors from 15 mL to 5 L.
Keywords
About the authors
A. W. Nienow
School of Chemical Engineering; Centre for Biological Engineering
Author for correspondence.
Email: a.w.nienow@bham.ac.uk
United Kingdom, Birmingham, B15 2TT; Loughborough, LE11 3TU
Q. A. Rafiq
Centre for Biological Engineering; Aston Medical Research Institute
Email: a.w.nienow@bham.ac.uk
United Kingdom, Loughborough, LE11 3TU; Birmingham, B4 7ET
T. R. J. Heathman
Centre for Biological Engineering
Email: a.w.nienow@bham.ac.uk
United Kingdom, Loughborough, LE11 3TU
K. Coopman
Centre for Biological Engineering
Email: a.w.nienow@bham.ac.uk
United Kingdom, Loughborough, LE11 3TU
C. J. Hewitt
Centre for Biological Engineering; Aston Medical Research Institute
Email: a.w.nienow@bham.ac.uk
United Kingdom, Loughborough, LE11 3TU; Birmingham, B4 7ET
Supplementary files
